Our Opportunities in Review webinar on Monday night’s are for members only.
If you sign up for a free 30 day trial, you will be included and a link to the webinar will be sent fifteen minutes before the start time.
The webinar start time will be 7pm tonight.
Start a trial today here.
For more detail on how you can access our model portfolio and receive emailed instructions, please call 1300 614 002.
For more detail on how you can access our model portfolio and receive emailed instructions, please call 1300 614 002.
CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
12/4 CIMIC is now trading above the 10 day average.
A2M:ASX is a high-risk recovery play into the second half of 2021. The driver will be a stabilization in the earnings picture and/or the potential for a takeover offer.
Investors may consider delaying the entry until we see a break above the 10 day average.
8/4/21
The buy condition is now triggered with today’s price action above the 10-day average.
12/4
A2 Milk is now trading above the 10 day average.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
.
For our Members, please find below the list of our latest Model Portfolio changes.
ALU:ASX is under Algo Engine buy conditions and we now add this to our watch list for a potential entry near the $27 range.
A further update will be provided during Monday night’s webinar, which will include details on the recent earnings for Altium.
Our Algo Engine has closed out the GDX ETF position for a 52.33% gain.
Amcor is under Algo Engine buy conditions. We expect buying support to increase around $14.50 – $15.00
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.